Alessia Mira

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy”.

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Nature(2024)10.1038/s41586-024-07205-6

N/A

4.2DataRank · unranked

326 citations

Bianca J. Lee, Jingjing Jiang, Aidan C.A. Tomlinson, Kyle J. Seamon, Alessia Mira +48 more

A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine

Nature Communications(2022)10.1038/s41467-022-29085-y

N/A

0.557DataRank · unranked

40 citations

Christina M. Ferrer, Maria Paola Serra, Jee-Eun Choi, Nadia Ducano, Alessia Mira +20 more

How to manage KRAS G12C-mutated advanced non-small-cell lung cancer

Drugs in Context(2022)10.7573/dic.2022-7-4

N/A

0DataRank · unranked

13 citations

Alessia Mira, Elisa Andrini, Pietro Scaparone, Sandra Vietti Michelina, Federica Pecci +6 more

The RAF/MEK clamp VS-6766 shows strong anti-tumor activity across multiple MAPK pathway alterations, with a preferential effect on KRAS G12V

European Journal of Cancer(2022)10.1016/s0959-8049(22)00851-6

N/A

0DataRank · unranked

0 citations

Mónica Musteanu, Alessia Mira, C. Caffarra, Deborah K. Morrison, Chiara Ambrogio +3 more

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

UNC Libraries(2024)10.17615/1fr6-tv06

N/A

0DataRank · unranked

0 citations

Nicole Nasholm, Chiara Ambrogio, Anthony N. Milin, Yang Liu, Elsa Quintana +48 more